Cargando…
Mathematical models of targeted cancer therapy
Improved understanding of the molecular underpinnings of cancer initiation and progression has led to the development of targeted cancer therapies. The importance of these new methods of cancer treatment necessitates further research into the dynamic interactions between cancer cells and therapeutic...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360553/ https://www.ncbi.nlm.nih.gov/pubmed/17031409 http://dx.doi.org/10.1038/sj.bjc.6603310 |
_version_ | 1782153077988524032 |
---|---|
author | Abbott, L H Michor, F |
author_facet | Abbott, L H Michor, F |
author_sort | Abbott, L H |
collection | PubMed |
description | Improved understanding of the molecular underpinnings of cancer initiation and progression has led to the development of targeted cancer therapies. The importance of these new methods of cancer treatment necessitates further research into the dynamic interactions between cancer cells and therapeutic agents, as well as a means of analysing their relationship quantitatively. The present review outlines the application of mathematical modelling to the dynamics of targeted cancer therapy, focusing particular attention on chronic myeloid leukaemia and its treatment with imatinib (Glivec). |
format | Text |
id | pubmed-2360553 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-23605532009-09-10 Mathematical models of targeted cancer therapy Abbott, L H Michor, F Br J Cancer Minireview Improved understanding of the molecular underpinnings of cancer initiation and progression has led to the development of targeted cancer therapies. The importance of these new methods of cancer treatment necessitates further research into the dynamic interactions between cancer cells and therapeutic agents, as well as a means of analysing their relationship quantitatively. The present review outlines the application of mathematical modelling to the dynamics of targeted cancer therapy, focusing particular attention on chronic myeloid leukaemia and its treatment with imatinib (Glivec). Nature Publishing Group 2006-11-06 2006-10-10 /pmc/articles/PMC2360553/ /pubmed/17031409 http://dx.doi.org/10.1038/sj.bjc.6603310 Text en Copyright © 2006 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Minireview Abbott, L H Michor, F Mathematical models of targeted cancer therapy |
title | Mathematical models of targeted cancer therapy |
title_full | Mathematical models of targeted cancer therapy |
title_fullStr | Mathematical models of targeted cancer therapy |
title_full_unstemmed | Mathematical models of targeted cancer therapy |
title_short | Mathematical models of targeted cancer therapy |
title_sort | mathematical models of targeted cancer therapy |
topic | Minireview |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360553/ https://www.ncbi.nlm.nih.gov/pubmed/17031409 http://dx.doi.org/10.1038/sj.bjc.6603310 |
work_keys_str_mv | AT abbottlh mathematicalmodelsoftargetedcancertherapy AT michorf mathematicalmodelsoftargetedcancertherapy |